Therapeutic Asset Ratings
5,108 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ISOCYCLOPHOSPHAMIDE
B-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
P3
BB
(66)
ISOCYCLOPHOSPHAMIDE
Non-Hodgkin Lymphoma
The Affiliated People's Hospital of Ningbo University
P3
BB
(66)
ISOCYCLOPHOSPHAMIDE
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(66)
ISOCYCLOPHOSPHAMIDE
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
University of California, Davis
P3
BB
(66)
Ivosidenib
Acute Myeloid Leukemia With Multilineage Dysplasia
Institut de Recherches Internationales Servier
P3
BB
(66)
JCAR-017 CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
Diffuse Large B-Cell Lymphoma
Lyell Immunopharma, Inc.
P3
BB
(66)
LATREPIRDINE
Alzheimer Disease
Bigespas LTD
P3
BB
(66)
L-CYSTEINAMIDE, D-PHENYLALANYL-L-CYSTEINYL-L-PHENYLALANYL-D-TRYPTOPHYL-L-LYSYL-L-THREONYL-N-(2-HYDROXY-1-(HYDROXYMETHYL)PROPYL)-, CYCLIC (2->7)-DISULFIDE, (R-(R*,R*))-
Digestive System Neuroendocrine Neoplasm
Novartis Pharmaceuticals
P3
BB
(66)
LECANEMAB
Familial Alzheimer Disease
Washington University School of Medicine
P3
BB
(66)
LENALIDOMIDE
Anaplastic Large Cell Lymphoma
Children's Cancer Group, China
P3
BB
(66)
LENALIDOMIDE
Non-Hodgkin Lymphoma
University of Cologne
P3
BB
(66)
LENALIDOMIDE
Smoldering Plasma Cell Myeloma
Irene Ghobrial, MD
P3
BB
(66)
Letrozole
Metastatic Malignant Neoplasm
UNICANCER
P3
BB
(66)
Letrozole
Estrogen-Receptor Positive Breast Cancer
National Cancer Institute (NCI)
P3
BB
(66)
Letrozole
Ovarian Carcinoma
OHSU Knight Cancer Institute
P3
BB
(66)
Letrozole
Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.
P3
BB
(66)
Lifileucel
Cutaneous Melanoma
Vastra Gotaland Region
P3
BB
(66)
Linvoseltamab
Smoldering Plasma Cell Myeloma
Regeneron Pharmaceuticals
P3
BB
(66)
Loperamide
Diarrheal Disease
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(66)
Lumateperone
Bipolar Depression
Intra-Cellular Therapies, Inc.
P3
BB
(66)
Lurbinectedin
Small Cell Carcinoma
SystImmune Inc.
P3
BB
(66)
Lurbinectedin
Small Cell Lung Carcinoma
Sichuan University
P3
BB
(66)
MELPHALAN
Leukemia
Shanghai Jiao Tong University School of Medicine
P3
BB
(66)
MELPHALAN
Myelodysplastic Syndrome
City of Hope Medical Center
P3
BB
(66)
MERCAPTOPURINE ANHYDROUS
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(66)
Showing 1226 to 1250 of 5,108 assets
Previous
Page 50 of 205
Next